News

Researchers explain why some tumors recur and how the recurrance can be prevented.

Advancing nanopore sensing towards lower cost and more accurate DNA sequencing.

Researchers have created a synthetic, modified E.coli genome to have favourable properties for medical research.

Researchers have found the genes behind aggressive ovarian and endometrial cancers.

Study suggests abnormalities in gene networks offer better therapy response prediction than individual genes.

The results of the analysis of 8,161 tissue samples could in the future help clinicians decide how best to treat a patient as well as aid the development of new targeted treatments.

Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.

"Can you believe they make DNA sequencers the size of staplers?" asked Meni Wanunu, Ph.D. "Ideas that were crazy twenty years ago are now happening!"

Decision does not impact Patisiran or any other RNAi therapeutic program in development.

The test is intended to simultaneously detect the presence of Flu A, Flu B and RSV RNA present in nasopharyngeal swabs samples collected from individuals at risk of infection.